Crawford

Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer
E. David Crawford, MD, professor of Radiation Oncology, Department of Surgery, University of Colorado Denver, discusses factors in selecting treatment with abiraterone acetate (Zytiga) versus enzalutamide (Xtandi) for patients with castration-resistant ... [...]
4
Like
Save